Halozyme Therapeutics, Inc. (HALO) shares up after passing $1 billion in revenue for first time, strong guidance.
4don MSN
While price strength in commodities in general has largely been driven by the weakening of the U.S. dollar, idiosyncratic ...
From crude oil to coffee, this FREE newsletter is for industry pros and rookies alike I don't usually spend much time ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback